A hot ETF now gets a 2x clone in 24 hours, and allocators inherit the vetting bill

Rex Shares and Tuttle Capital Management are preparing four ETFs that would go 2x long or 2x inverse on Roundhill's brand new Neocloud and Photonics & Optics funds, and they filed with the Securities and Exchange Commission one day after the Roundhill funds hit the market ^[1][2]. That turnaround is the story: a launch no longer produces a fund, it produces a small family of geared instruments trading on the same theme, and whoever screens products for a platform or a model portfolio now has to vet the family.

The clones are not confined to outsiders. Roundhill filed for its own 2x long version of LYTE, and Leverage Shares filed last week for a 2x ETF focused on the same fund ^[3][4]. The template already exists in memory chips. At least four funds go long or short on Roundhill's $27 billion Memory ETF, DRAM ^[7]. The $630 million 2x Long DRAM Daily Target ETF is a collaboration between Roundhill and T-REX; the T-REX 2x Inverse DRAM Daily Target ETF, RAMZ, is not ^[8][9]. So the leveraged sleeve on DRAM sits at roughly 2 percent of the underlying fund's assets ^[21], which tells you something about where the money actually is, and something about how cheap it is to try.

Tuttle CEO Matthew Tuttle is blunt about the odds. "To the best of my knowledge nobody has been able to get critical mass in 2X themes," he told ETF Upside, adding that leverage traders generally want single stocks, with DRAM an exception because it got so big so fast, and that his firm is looking at LYTE and NCLD the same way ^[5][6]. Roundhill CEO Dave Mazza framed the filings as flattery: "We take these filings as a compliment, since firms only file 2x versions of funds that are clearly resonating with investors," while noting a difference between identifying an opportunity early and chasing one after the fact ^[10].

The aggregate numbers explain the behaviour better than either quote. Leveraged and inverse equity ETFs held about 1 percent of the $15.7 trillion ETF market at the end of July, per Morningstar Direct, or roughly $157 billion ^[11][20]. Net flows were unimpressive: money left leveraged equity ETFs and went into inverse equity ETFs, with total flows just over 0.1 percent of the more than $1 trillion in US ETF flows this year, on the order of $1 billion ^[12][22]. Supply is doing something else entirely. Of 621 leveraged equity ETFs on the market, 276 launched this year, about 44 percent of the category ^[13][18]. Of 166 inverse equity ETFs, 23 arrived year to date, near 14 percent ^[14][19].

Todd Sohn, chief ETF strategist at Baird Strategas, put the competitive logic plainly: below the heavyweights there is a midcap tier that cannot win by launching another S&P 500 fund, so it chases themes, and "it becomes a knife fight, but there aren't enough assets to go around" ^[15][16]. He expects casualties: "Then you end up with 10 ETFs with nothing in them," and of the thematic wave due in the next three months, "I have no idea who is buying them" ^[17].

Watch three things. Whether the geared sleeve on LYTE or NCLD ever reaches the scale DRAM's did, which is the only evidence that 2x themes clear ^[5][7]. Whether flows follow the 276 new leveraged listings or stay negative ^[12][13]. And whether platforms start distinguishing an issuer's own geared line from a competitor's uninvited one, because Roundhill has now done both ^[3][8].